AMD3100 protects from UV-induced skin cancer

OncoImmunology

Volumn 3, Issue 1, 2014, Pages

  Byrne, Scott N ^a,b   Sarchio, Seri N E ^a,b,c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

Chemokines; Immunosuppression; Mast cells; Skin cancer; Sunlight; Ultraviolet radiation

Indexed keywords

PLERIXAFOR; SUNSCREEN;

ARTICLE; CANCER INCIDENCE; CANCER PREVENTION; DRUG ACTIVITY; DRUG MECHANISM; DRUG POTENCY; HUMAN; LONG TERM EXPOSURE; NONHUMAN; PHARMACOLOGICAL BLOCKING; SQUAMOUS CELL CARCINOMA; SUN EXPOSURE; ULTRAVIOLET RADIATION;

EID: 84899049135     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.27562     Document Type: Article

References (10)

1. Ullrich SE, Byrne SN. The immunologic revolution: photoimmunology. J Invest Dermatol 2012; 132:896-905; http://dx.doi.org/10.1038/jid.2011.405; PMID:22170491.
2. Grimbaldeston MA, Nakae S, Kalesnikoff J, Tsai M, Galli SJ. Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B. Nat Immunol 2007; 8:1095-104; http://dx.doi.org/10.1038/ni1503; PMID:17767162.
3. Hart PH, Grimbaldeston MA, Swift GJ, Jaksic A, Noonan FP, Finlay-Jones JJ. Dermal mast cells determine susceptibility to ultraviolet B-induced systemic suppression of contact hypersensitivity responses in mice. J Exp Med 1998; 187:2045-53; http://dx.doi. org/10.1084/jem.187.12.2045; PMID:9625764.
4. Byrne SN, Limón-Flores AY, Ullrich SE. Mast cell migration from the skin to the draining lymph nodes upon ultraviolet irradiation represents a key step in the induction of immune suppression. J Immunol 2008; 180:4648-55; PMID:18354188.
5. Righi E, Kashiwagi S, Yuan J, Santosuosso M, Leblanc P, Ingraham R, Forbes B, Edelblute B, Collette B, Xing D, et al. CXCL12/CXCR4 blockade induces multimodal antitumor effects that prolong survival in an immunocompetent mouse model of ovarian cancer. Cancer Res 2011; 71:5522-34; http://dx.doi.org/10.1158/0008-5472.CAN-10-3143; PMID:21742774.
6. D'Alterio C, Barbieri A, Portella L, Palma G, Polimeno M, Riccio A, Ieranò C, Franco R, Scognamiglio G, Bryce J, et al. Inhibition of stromal CXCR4 impairs development of lung metastases. Cancer Immunol Immunother 2012; 61:1713-20; http://dx.doi. org/10.1007/s00262-012-1223-7; PMID:22399057.
7. Ma Y, Hwang RF, Logsdon CD, Ullrich SE. Dynamic mast cell-stromal cell interactions promote growth of pancreatic cancer. Cancer Res 2013; 73:3927-37; http://dx.doi.org/10.1158/0008-5472.CAN-12-4479; PMID:23633481.
8. Sarchio SNE, Scolyer RA, Beaugie C, McDonald D, Marsh-Wakefield F, Halliday GM, Byrne SN. Pharmacologically antagonizing the CXCR4-CXCL12 chemokine pathway with AMD3100 inhibits sunlight-induced skin cancer. J Invest Dermatol 2014; 134:1091-100; http://dx.doi.org/10.1038/jid.2013.424; PMID:24226205.
9. Halliday GM, Damian DL, Rana S, Byrne SN. The suppressive effects of ultraviolet radiation on immunity in the skin and internal organs: implications for autoimmunity. J Dermatol Sci 2012; 66:176-82; http://dx.doi.org/10.1016/j.jdermsci.2011.12.009; PMID:22277701.
10. Surjana D, Halliday GM, Martin AJ, Moloney FJ, Damian DL. Oral nicotinamide reduces actinic keratoses in phase II double-blinded randomized controlled trials. J Invest Dermatol 2012; 132:1497-500; http://dx.doi.org/10.1038/jid.2011.459; PMID:22297641.